CEO Mark J Foley sold $961K of Revance Therapeutics, Inc.

Sold$960,928

$30.72Price

31,279Shares

−3%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Fri, Jun 9. Filed Tue, Jun 13, 4:09 PM ET, after the close. Not investment advice.